Starnatx

$40MTotal raised
Data updated Nov 21, 2026Money ledger: 1 record from 1 sourcePress 1Full reportReport a mistake

Facts

as of Nov 21, 2026

星锐医药(Starna Therapeutics) 成立于2021年8月,公司聚焦肝外靶向递送技术,致力于研发以RNA为核心的创新药物,解决未被满足的临床需求。核心团队来自知名药企、高校和研究院所,团队拥有深厚的核酸药物发现、递送技术和制剂开发能力。.

Headquarters
Suzhou, China
Founded
2021
Employees
51-200estimated range

These are the key facts about Starnatx on Alion as of Nov 21, 2026. Starnatx is headquartered in Suzhou, China. It was founded in 2021. The latest round is Series B of $40M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Starnatx has $40M paid in by investors, lenders and donors.

$40MPaid in
Money innewest first
Equity raised
May 2026 · Series B
$40MPaid
Money by yearUSD, rounds and grants
2026$40M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Suzhou ChinaHeadquarters0
Source: office addresses in postings and company registers

Milestones

May 11
Raised a round Series B $40M
2021
Founded
Each milestone is dated by its source: registers, filings, the press